دورية أكاديمية
Imatinib dose escalation for chronic phase–chronic myelogenous leukaemia patients in primary suboptimal response to imatinib 400 mg daily standard therapy
العنوان: | Imatinib dose escalation for chronic phase–chronic myelogenous leukaemia patients in primary suboptimal response to imatinib 400 mg daily standard therapy |
---|---|
المؤلفون: | Rea, DAff1, Aff2, IDleu200932_cor1, Etienne, GAff2, Aff3, Corm, SAff2, Aff4, Cony-Makhoul, PAff2, Aff5, Gardembas, MAff2, Aff6, Legros, LAff2, Aff7, Dubruille, VAff2, Aff8, Hayette, SAff2, Aff9, Mahon, F-XAff2, Aff3, Aff10, Cayuela, J-MAff2, Aff11, Nicolini, F EAff2, Aff12 |
المصدر: | Leukemia. 23(6):1193-1196 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 08876924 14765551 |
---|---|
DOI: | 10.1038/leu.2009.32 |